1-877-327-4636 Alcohol and Substance
1-800-436-8477 Morning Sickness
1-888-246-5840 HIV and HIV Treatment
1-877-439-2744 Motherisk Helpline
416-813-6780 Motherisk Helpline
Pregnancy & Breastfeeding Resources
Current Studies at Motherisk
The Safety of Diclectin in Breastfeeding
Neurodevelopment of Children Exposed in-Utero to Chemotherapy for Maternal Breast Cancer (Dr. I Nulman)
Diclegis Surveillance Program Study
Diclectin Surveillance Program Study
Study seeks women between 4 and 12 weeks in their pregnancy with morning sickness (NVP)
Pregnancy in Women with Multiple Sclerosis
Alcohol Use during Pregnancy
Lamisil in Pregnancy
Meridia in Pregnancy
Autoimmune Diseases in Pregnancy Project
Current Studies at Motherisk: Neurodevelopment of Children Exposed in-Utero to Chemotherapy for Maternal Breast Cancer (Dr. I Nulman)
The Motherisk Program at The Hospital for Sick Children (SickKids) in Toronto is recruiting volunteers for a study on the physical health and neurodevelopmental outcomes of children exposed to maternal chemotherapy and/or surgery for breast cancer during pregnancy.
The findings of this research will help optimize breast cancer treatment during pregnancy, while minimizing the risks for the fetus.
Who is eligible to participate?
- Children up to 16 years of age who were exposed to maternal chemotherapy and/or surgery for breast cancer during pregnancy.
- The child's parents or primary care providers
What is involved in the study?
- Children will undergo a non-invasive physical examination and neuropsychological testing (IQ testing).
- Parents or care providers will answer questionnaires related to their child's health and behaviour.
You will receive monetary compensation for your participation and a detailed report on your child's performance.
To participate or for more information, please contact the study team by phone at 416-813-7329 or by email: firstname.lastname@example.org